Drug discovery

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #DMTA #Drug discovery

AI-augmented innovation: Enabling DMTA with digital-physical synergy

Andrew Anderson, Vice President, Innovation and Informatics Strategy at ACD/Labs, looks at how AI is enabling true drug design. Innovators in the pharma and biopharma sectors are actively seeking systems that accelerate the discovery, development, and commercialisation of new products. Of particular interest are systems to support the implementation of… Read More

#Exclusive Content

#Automation #Drug discovery #Lab technology #Labguru #Mergers and acquisitions #Titian

Labguru and Titian Software Rebrand as Cenevo

Titian Software and Labguru have rebranded as Cenevo, bringing together the two companies’ solutions, Labguru and Mosaic, under a new, unified brand.   The combined organisation specialises in lab management systems, automation, orchestration, data management and AI technology.  The new company says that Cenevo software will enable smart connected labs that… Read More

#Business & Investment #News

#Alzheimer's #Drug discovery #Neurodegenerative disorders #Neuroscience

New DDW Highlights podcast: 4 August 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the Alzheimer’s Association International Conference (AAIC) taking place this week in Toronto, Canada, there… Read More

#News

#AI / data analytics / healthtech / informatics #Drug discovery #Non-animal model (NAM) #Organ-on-a-chip #Preclinical development

What comes after animal models?  

Mariana Argenziano, Associate Director Manufacturing Technologies, and Jeroen de Groot, Divisional Chief Executive Officer at Ncardia, explore how human-relevant preclinical research can move the industry past its reliance on animal models.   In April 2025, the US Food and Drug Administration (FDA) released a roadmap to reducing animal testing in preclinical… Read More

#Exclusive Content

#Alzheimer's #Drug discovery #Neurodegenerative disorders #Neuroscience

This week in drug discovery (28 July – 1 August) 

News round-up for 28 July – 1 August by DDW Senior Digital Content Editor Diana Turner. With the Alzheimer’s Association International Conference (AAIC) taking place this week in Toronto, Canada, there have been a number of updates in the neuroscience drug discovery field. The top stories:… Read More

#News

#Biomedical research #Drug discovery #Spatial biology

Spatial biology: What you need to know about this revolutionary field

Dr Saška Brajkovic, Senior Director R&D, Lunaphore, Spatial Biology Division at Bio-Techne, explains how the spatial biology field is transforming our view of how various diseases function and leading to exciting new treatment possibilities. Spatial biology is rapidly gaining momentum across biomedical research. At the end of 2024, the field… Read More

#Exclusive Content

#Advanced Therapies #Biomanufacturing #Cell and gene therapy #Drug discovery #Manufacturing

New DDW Highlights podcast: 28 July 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. Following the recent news that the FDA rejected Ultragenyx Pharmaceutical’s gene therapy due to manufacturing concerns,… Read More

#News

#Advanced Therapies #Biomanufacturing #Cell and gene therapy #Drug discovery #Manufacturing

This week in drug discovery (21-25 July) 

News round-up for 21-25 July by DDW Senior Digital Content Editor Diana Turner. Following the recent news that the FDA rejected Ultragenyx Pharmaceutical’s gene therapy due to manufacturing concerns, manufacturing has dominated the headlines this week, particularly significant investment in facilities in the US, and new guidelines… Read More

#News

#Drug discovery #Drug targets #Enhanced Genomics #Genomics #Multi-omics

Part 2: A day exploring Cambridge’s life science scene

DDW’s Megan Thomas went to Cambridge, UK, to learn more about what’s happening in this life science epicentre. She spoke with several local companies and attended events. The first of this series was a conversation with Nicola Thompson, CEO of TRIMTECH Therapeutics. Here, DDW summarises what was learnt about Enhanced… Read More

#Exclusive Content

#Cancer research #Drug discovery #Personalised medicine #Perspective Therapeutics #Radiopharmaceuticals

New podcast: Redefining oncology with radiopharmaceuticals

In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Thijs Spoor, CEO… Read More

#News

London skyline
#Drug discovery #Events #Turning Science into Business Symposium

DDW Symposium attracts key drug discovery speakers

The DDW Turning Science into Business Symposium boasts a stellar line up of speakers sharing their insight on the opportunity and expertise within the drug discovery and development market. Later this year DDW will be holding its Turning Science into Business Symposium at the Francis Crick Institute in London. The… Read More

#Exclusive Content

#Advanced Therapies #Cell and gene therapy #Drug discovery #Gene therapy

New DDW Highlights podcast: 21 July 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week’s news highlights reflect the incredible levels of innovation and investment, but also the… Read More

#News

#Advanced Therapies #Cell and gene therapy #Drug discovery #Gene therapy

This week in drug discovery (14-18 July) 

News round-up for 14-18 July by DDW Senior Digital Content Editor Diana Turner. This week’s news highlights reflect the incredible levels of innovation and investment, but also the hurdles to overcome, in developing gene therapies – breakthrough treatments in many genetic diseases that can bring their own unique… Read More

#News

FDA headquarters
#Cancer research #Drug discovery #FDA #Fujifilm #Regulatory

FUJIFILM’s biliary tract cancer drug granted FDA orphan status

FUJIFILM Pharmaceuticals’ FF-10832—an investigational liposomal formulation of gemcitabine—has granted orphan drug designation for the treatment of biliary tract cancer (BTC) by the US Food and Drug Administration (FDA). FF-10832 is currently being evaluated in Phase IIa studies as monotherapy or in combination with pembrolizumab for the treatment of solid tumours… Read More

#Cancer Research #News

#Drug discovery #Europe #European Commission #European Union

New DDW Highlights podcast: 14 July 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week our news highlights focus on the drug discovery in the European Union, including… Read More

#News

#Artificial intelligence (AI) #Biopharma #Biotechnology #Drug discovery #Genetics / genomics

DDW Summer edition – out now!

The DDW Summer issue is available to read now. It features in-depth articles on the technologies and advancements driving genomics drug discovery, how supercomputing can drive neuroscience discoveries, and everything you need to know about spatial biology.  Other features include:   A market report on… Read More

#Editor's Choice #News